chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 18.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Blood fibrinogen decreased, Blood lactic acid, Blood thyroid stimulating hormone normal, Cerebral infarction, Cerebral venous sinus thrombosis
Clinical narrative: SAGITTAL SINUS THROMBOSIS; CEREBRAL HEMORRHAGE; SEIZURES; THROMBOCYTOPENIA; This spontaneous report was received from a pharmacist and concerned an 18-year-old female. Initial information was received on 03-APR-2021, with additional information obtained via telephone follow up from a physician on 07-APR-2021. The patient's height and weight were not reported. The patient had no known allergies, was a non-smoker, was not on oral contraceptives and was not on any medications. There was no history of clotting disorders for the patient and no family history of a clotting disorder. The patient received COVID-19 VACCINE AD26.COV2.S (suspension for injection, route of administration not reported, batch number and expiration date were not reported) on 16-MAR-2021. The batch number has been requested.  On 01-APR-2021, patient developed headaches, vomiting and mental status changes. The mother of the patient noted that she was "staring" or "spacey". She was brought to the hospital where CT scan (computerized tomogram) and MRI (magnetic resonance imaging) of the brain revealed sagittal sinus thrombosis and hemorrhage. The patient was admitted to the intensive care unit. Platelet count on presentation was 18,000 (units unspecified), fibrinogen was noted to be low (value not provided), fibrin D-dimer was elevated (specific levels not provided). The platelet counts remained 22,000 to 24,000. In the evening of 01-APR-2021, the patient developed seizures, was intubated, sedated and placed on unspecified anti-epileptics. The patient was treated using a platelet transfusion in preparation for thrombectomy, and was anticoagulated (specific agents not provided). Following platelet transfusion and thrombectomy, patient's platelet count rose to 160,000, fibrinogen normalized (value not provided), and both remained stable for 1-2 days. Treatment with unspecified anti-epileptics was continued. The patient remained intubated and sedated, and thus her mental and neurologic status was not re-evaluated. She was transferred to a tertiary care hospital in the evening of 06-APR-2021. The patient recovered from thrombocytopenia, and the outcome of sagittal sinus thrombosis, cerebral hemorrhage, and seizures was not reported. This report was serious (Hospitalization Caused / Prolonged, and Other Medically Important Condition).; Sender's Comments: V0:  This is a spontaneous report of an 18-year-old female who experienced cerebral venous sinus thrombosis with thrombocytopenia and low fibrinogen levels 16 days after receipt of the Janssen COVID-19 vaccine. The patient was treated with platelet transfusion and underwent thrombectomy, and remains in intensive care. Additional information has been requested.
Age: 18.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Coma scale, Double stranded DNA antibody, Fibrin D dimer, Human chorionic gonadotropin negative, Immunoglobulin therapy
Clinical narrative: SAGITTAL SINUS THROMBOSIS; CEREBRAL HEMORRHAGE; SEIZURES; THROMBOCYTOPENIA; This spontaneous report was received from a pharmacist and concerned an 18-year-old female. Initial information was received on 03-APR-2021, with additional information obtained via telephone follow up from a physician on 07-APR-2021. The patient's height and weight were not reported. The patient had no known allergies, was a non-smoker, was not on oral contraceptives and was not on any medications. There was no history of clotting disorders for the patient and no family history of a clotting disorder. The patient received COVID-19 VACCINE AD26.COV2.S (suspension for injection, route of administration not reported, batch number and expiration date were not reported) on 16-MAR-2021. The batch number has been requested.  On 01-APR-2021, patient developed headaches, vomiting and mental status changes. The mother of the patient noted that she was "staring" or "spacey". She was brought to the hospital where CT scan (computerized tomogram) and MRI (magnetic resonance imaging) of the brain revealed sagittal sinus thrombosis and hemorrhage. The patient was admitted to the intensive care unit. Platelet count on presentation was 18,000 (units unspecified), fibrinogen was noted to be low (value not provided), fibrin D-dimer was elevated (specific levels not provided). The platelet counts remained 22,000 to 24,000. In the evening of 01-APR-2021, the patient developed seizures, was intubated, sedated and placed on unspecified anti-epileptics. The patient was treated using a platelet transfusion in preparation for thrombectomy, and was anticoagulated (specific agents not provided). Following platelet transfusion and thrombectomy, patient's platelet count rose to 160,000, fibrinogen normalized (value not provided), and both remained stable for 1-2 days. Treatment with unspecified anti-epileptics was continued. The patient remained intubated and sedated, and thus her mental and neurologic status was not re-evaluated. She was transferred to a tertiary care hospital in the evening of 06-APR-2021. The patient recovered from thrombocytopenia, and the outcome of sagittal sinus thrombosis, cerebral hemorrhage, and seizures was not reported. This report was serious (Hospitalization Caused / Prolonged, and Other Medically Important Condition).; Sender's Comments: V0:  This is a spontaneous report of an 18-year-old female who experienced cerebral venous sinus thrombosis with thrombocytopenia and low fibrinogen levels 16 days after receipt of the Janssen COVID-19 vaccine. The patient was treated with platelet transfusion and underwent thrombectomy, and remains in intensive care. Additional information has been requested.
Age: 18.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: International normalised ratio increased, Mechanical ventilation, Nausea, Platelet count decreased, Staphylococcal infection
Clinical narrative: SAGITTAL SINUS THROMBOSIS; CEREBRAL HEMORRHAGE; SEIZURES; THROMBOCYTOPENIA; This spontaneous report was received from a pharmacist and concerned an 18-year-old female. Initial information was received on 03-APR-2021, with additional information obtained via telephone follow up from a physician on 07-APR-2021. The patient's height and weight were not reported. The patient had no known allergies, was a non-smoker, was not on oral contraceptives and was not on any medications. There was no history of clotting disorders for the patient and no family history of a clotting disorder. The patient received COVID-19 VACCINE AD26.COV2.S (suspension for injection, route of administration not reported, batch number and expiration date were not reported) on 16-MAR-2021. The batch number has been requested.  On 01-APR-2021, patient developed headaches, vomiting and mental status changes. The mother of the patient noted that she was "staring" or "spacey". She was brought to the hospital where CT scan (computerized tomogram) and MRI (magnetic resonance imaging) of the brain revealed sagittal sinus thrombosis and hemorrhage. The patient was admitted to the intensive care unit. Platelet count on presentation was 18,000 (units unspecified), fibrinogen was noted to be low (value not provided), fibrin D-dimer was elevated (specific levels not provided). The platelet counts remained 22,000 to 24,000. In the evening of 01-APR-2021, the patient developed seizures, was intubated, sedated and placed on unspecified anti-epileptics. The patient was treated using a platelet transfusion in preparation for thrombectomy, and was anticoagulated (specific agents not provided). Following platelet transfusion and thrombectomy, patient's platelet count rose to 160,000, fibrinogen normalized (value not provided), and both remained stable for 1-2 days. Treatment with unspecified anti-epileptics was continued. The patient remained intubated and sedated, and thus her mental and neurologic status was not re-evaluated. She was transferred to a tertiary care hospital in the evening of 06-APR-2021. The patient recovered from thrombocytopenia, and the outcome of sagittal sinus thrombosis, cerebral hemorrhage, and seizures was not reported. This report was serious (Hospitalization Caused / Prolonged, and Other Medically Important Condition).; Sender's Comments: V0:  This is a spontaneous report of an 18-year-old female who experienced cerebral venous sinus thrombosis with thrombocytopenia and low fibrinogen levels 16 days after receipt of the Janssen COVID-19 vaccine. The patient was treated with platelet transfusion and underwent thrombectomy, and remains in intensive care. Additional information has been requested.
Age: 18.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Staphylococcus test positive, Thrombectomy, Thrombocytopenia, Thyroxine free normal, Vomiting
Clinical narrative: SAGITTAL SINUS THROMBOSIS; CEREBRAL HEMORRHAGE; SEIZURES; THROMBOCYTOPENIA; This spontaneous report was received from a pharmacist and concerned an 18-year-old female. Initial information was received on 03-APR-2021, with additional information obtained via telephone follow up from a physician on 07-APR-2021. The patient's height and weight were not reported. The patient had no known allergies, was a non-smoker, was not on oral contraceptives and was not on any medications. There was no history of clotting disorders for the patient and no family history of a clotting disorder. The patient received COVID-19 VACCINE AD26.COV2.S (suspension for injection, route of administration not reported, batch number and expiration date were not reported) on 16-MAR-2021. The batch number has been requested.  On 01-APR-2021, patient developed headaches, vomiting and mental status changes. The mother of the patient noted that she was "staring" or "spacey". She was brought to the hospital where CT scan (computerized tomogram) and MRI (magnetic resonance imaging) of the brain revealed sagittal sinus thrombosis and hemorrhage. The patient was admitted to the intensive care unit. Platelet count on presentation was 18,000 (units unspecified), fibrinogen was noted to be low (value not provided), fibrin D-dimer was elevated (specific levels not provided). The platelet counts remained 22,000 to 24,000. In the evening of 01-APR-2021, the patient developed seizures, was intubated, sedated and placed on unspecified anti-epileptics. The patient was treated using a platelet transfusion in preparation for thrombectomy, and was anticoagulated (specific agents not provided). Following platelet transfusion and thrombectomy, patient's platelet count rose to 160,000, fibrinogen normalized (value not provided), and both remained stable for 1-2 days. Treatment with unspecified anti-epileptics was continued. The patient remained intubated and sedated, and thus her mental and neurologic status was not re-evaluated. She was transferred to a tertiary care hospital in the evening of 06-APR-2021. The patient recovered from thrombocytopenia, and the outcome of sagittal sinus thrombosis, cerebral hemorrhage, and seizures was not reported. This report was serious (Hospitalization Caused / Prolonged, and Other Medically Important Condition).; Sender's Comments: V0:  This is a spontaneous report of an 18-year-old female who experienced cerebral venous sinus thrombosis with thrombocytopenia and low fibrinogen levels 16 days after receipt of the Janssen COVID-19 vaccine. The patient was treated with platelet transfusion and underwent thrombectomy, and remains in intensive care. Additional information has been requested.
Age: 18.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: White blood cell count normal
Clinical narrative: SAGITTAL SINUS THROMBOSIS; CEREBRAL HEMORRHAGE; SEIZURES; THROMBOCYTOPENIA; This spontaneous report was received from a pharmacist and concerned an 18-year-old female. Initial information was received on 03-APR-2021, with additional information obtained via telephone follow up from a physician on 07-APR-2021. The patient's height and weight were not reported. The patient had no known allergies, was a non-smoker, was not on oral contraceptives and was not on any medications. There was no history of clotting disorders for the patient and no family history of a clotting disorder. The patient received COVID-19 VACCINE AD26.COV2.S (suspension for injection, route of administration not reported, batch number and expiration date were not reported) on 16-MAR-2021. The batch number has been requested.  On 01-APR-2021, patient developed headaches, vomiting and mental status changes. The mother of the patient noted that she was "staring" or "spacey". She was brought to the hospital where CT scan (computerized tomogram) and MRI (magnetic resonance imaging) of the brain revealed sagittal sinus thrombosis and hemorrhage. The patient was admitted to the intensive care unit. Platelet count on presentation was 18,000 (units unspecified), fibrinogen was noted to be low (value not provided), fibrin D-dimer was elevated (specific levels not provided). The platelet counts remained 22,000 to 24,000. In the evening of 01-APR-2021, the patient developed seizures, was intubated, sedated and placed on unspecified anti-epileptics. The patient was treated using a platelet transfusion in preparation for thrombectomy, and was anticoagulated (specific agents not provided). Following platelet transfusion and thrombectomy, patient's platelet count rose to 160,000, fibrinogen normalized (value not provided), and both remained stable for 1-2 days. Treatment with unspecified anti-epileptics was continued. The patient remained intubated and sedated, and thus her mental and neurologic status was not re-evaluated. She was transferred to a tertiary care hospital in the evening of 06-APR-2021. The patient recovered from thrombocytopenia, and the outcome of sagittal sinus thrombosis, cerebral hemorrhage, and seizures was not reported. This report was serious (Hospitalization Caused / Prolonged, and Other Medically Important Condition).; Sender's Comments: V0:  This is a spontaneous report of an 18-year-old female who experienced cerebral venous sinus thrombosis with thrombocytopenia and low fibrinogen levels 16 days after receipt of the Janssen COVID-19 vaccine. The patient was treated with platelet transfusion and underwent thrombectomy, and remains in intensive care. Additional information has been requested.
Age: 18.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Brain operation, Cerebral haemorrhage, Cerebrovascular accident, Coma, Loss of personal independence in daily activities
Clinical narrative: SAGITTAL SINUS THROMBOSIS; CEREBRAL HEMORRHAGE; SEIZURES; THROMBOCYTOPENIA; This spontaneous report was received from a pharmacist and concerned an 18-year-old female. Initial information was received on 03-APR-2021, with additional information obtained via telephone follow up from a physician on 07-APR-2021. The patient's height and weight were not reported. The patient had no known allergies, was a non-smoker, was not on oral contraceptives and was not on any medications. There was no history of clotting disorders for the patient and no family history of a clotting disorder. The patient received COVID-19 VACCINE AD26.COV2.S (suspension for injection, route of administration not reported, batch number and expiration date were not reported) on 16-MAR-2021. The batch number has been requested.  On 01-APR-2021, patient developed headaches, vomiting and mental status changes. The mother of the patient noted that she was "staring" or "spacey". She was brought to the hospital where CT scan (computerized tomogram) and MRI (magnetic resonance imaging) of the brain revealed sagittal sinus thrombosis and hemorrhage. The patient was admitted to the intensive care unit. Platelet count on presentation was 18,000 (units unspecified), fibrinogen was noted to be low (value not provided), fibrin D-dimer was elevated (specific levels not provided). The platelet counts remained 22,000 to 24,000. In the evening of 01-APR-2021, the patient developed seizures, was intubated, sedated and placed on unspecified anti-epileptics. The patient was treated using a platelet transfusion in preparation for thrombectomy, and was anticoagulated (specific agents not provided). Following platelet transfusion and thrombectomy, patient's platelet count rose to 160,000, fibrinogen normalized (value not provided), and both remained stable for 1-2 days. Treatment with unspecified anti-epileptics was continued. The patient remained intubated and sedated, and thus her mental and neurologic status was not re-evaluated. She was transferred to a tertiary care hospital in the evening of 06-APR-2021. The patient recovered from thrombocytopenia, and the outcome of sagittal sinus thrombosis, cerebral hemorrhage, and seizures was not reported. This report was serious (Hospitalization Caused / Prolonged, and Other Medically Important Condition).; Sender's Comments: V0:  This is a spontaneous report of an 18-year-old female who experienced cerebral venous sinus thrombosis with thrombocytopenia and low fibrinogen levels 16 days after receipt of the Janssen COVID-19 vaccine. The patient was treated with platelet transfusion and underwent thrombectomy, and remains in intensive care. Additional information has been requested.
Age: 18.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Mechanical ventilation, Seizure, Thrombosis, Wheelchair user
Clinical narrative: SAGITTAL SINUS THROMBOSIS; CEREBRAL HEMORRHAGE; SEIZURES; THROMBOCYTOPENIA; This spontaneous report was received from a pharmacist and concerned an 18-year-old female. Initial information was received on 03-APR-2021, with additional information obtained via telephone follow up from a physician on 07-APR-2021. The patient's height and weight were not reported. The patient had no known allergies, was a non-smoker, was not on oral contraceptives and was not on any medications. There was no history of clotting disorders for the patient and no family history of a clotting disorder. The patient received COVID-19 VACCINE AD26.COV2.S (suspension for injection, route of administration not reported, batch number and expiration date were not reported) on 16-MAR-2021. The batch number has been requested.  On 01-APR-2021, patient developed headaches, vomiting and mental status changes. The mother of the patient noted that she was "staring" or "spacey". She was brought to the hospital where CT scan (computerized tomogram) and MRI (magnetic resonance imaging) of the brain revealed sagittal sinus thrombosis and hemorrhage. The patient was admitted to the intensive care unit. Platelet count on presentation was 18,000 (units unspecified), fibrinogen was noted to be low (value not provided), fibrin D-dimer was elevated (specific levels not provided). The platelet counts remained 22,000 to 24,000. In the evening of 01-APR-2021, the patient developed seizures, was intubated, sedated and placed on unspecified anti-epileptics. The patient was treated using a platelet transfusion in preparation for thrombectomy, and was anticoagulated (specific agents not provided). Following platelet transfusion and thrombectomy, patient's platelet count rose to 160,000, fibrinogen normalized (value not provided), and both remained stable for 1-2 days. Treatment with unspecified anti-epileptics was continued. The patient remained intubated and sedated, and thus her mental and neurologic status was not re-evaluated. She was transferred to a tertiary care hospital in the evening of 06-APR-2021. The patient recovered from thrombocytopenia, and the outcome of sagittal sinus thrombosis, cerebral hemorrhage, and seizures was not reported. This report was serious (Hospitalization Caused / Prolonged, and Other Medically Important Condition).; Sender's Comments: V0:  This is a spontaneous report of an 18-year-old female who experienced cerebral venous sinus thrombosis with thrombocytopenia and low fibrinogen levels 16 days after receipt of the Janssen COVID-19 vaccine. The patient was treated with platelet transfusion and underwent thrombectomy, and remains in intensive care. Additional information has been requested.
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain, Cerebrovascular accident, Dyspnoea, Flushing, Hyperhidrosis
Clinical narrative: History of Present Illness     This is a healthy 33-year-old female presenting to the emergency depart with medics after having a syncopal event after getting the COVID-19 vaccine.  She states that she was otherwise feeling well today, exercise on her Peloton bike today with no problems, received her COVID vaccine and shortly after her vaccine started to feel dizzy and light headed. She tells me she was reading an article on her phone about cats when she suddenly started to feel dizzy, lightheaded, felt like she could not see, and she could not feel her hands and legs.  The next thing she remembers is receiving a shot of epinephrine.  She denies any lip swelling, tongue swelling, rashes on her body, or extremity itchiness.  Currently states that she feels like the back of her throat he has a little bit itchy.  Denies any abdominal pain, headache, neck pain, or numbness or weakness at this time.   She was given 0.3mg SQ epi x 2 in the pharmacy. When medics arrived on scene, she was awake, moving all extremities, lungs were clear bilaterally.  Blood pressure was 130/90, heart rate was 100 (NSR).    She tells me her two biggest complaints at this time is that she feels like her heart is racing after the epinephrine shot and she has some mild itchiness in the back of her throat.   Reports she has a history of allergy to multiple medications and an allergy to the chickenpox vaccine.
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypoaesthesia, Hypotension, Nausea, Paraesthesia, Syncope
Clinical narrative: History of Present Illness     This is a healthy 33-year-old female presenting to the emergency depart with medics after having a syncopal event after getting the COVID-19 vaccine.  She states that she was otherwise feeling well today, exercise on her Peloton bike today with no problems, received her COVID vaccine and shortly after her vaccine started to feel dizzy and light headed. She tells me she was reading an article on her phone about cats when she suddenly started to feel dizzy, lightheaded, felt like she could not see, and she could not feel her hands and legs.  The next thing she remembers is receiving a shot of epinephrine.  She denies any lip swelling, tongue swelling, rashes on her body, or extremity itchiness.  Currently states that she feels like the back of her throat he has a little bit itchy.  Denies any abdominal pain, headache, neck pain, or numbness or weakness at this time.   She was given 0.3mg SQ epi x 2 in the pharmacy. When medics arrived on scene, she was awake, moving all extremities, lungs were clear bilaterally.  Blood pressure was 130/90, heart rate was 100 (NSR).    She tells me her two biggest complaints at this time is that she feels like her heart is racing after the epinephrine shot and she has some mild itchiness in the back of her throat.   Reports she has a history of allergy to multiple medications and an allergy to the chickenpox vaccine.
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Unresponsive to stimuli, Vomiting
Clinical narrative: History of Present Illness     This is a healthy 33-year-old female presenting to the emergency depart with medics after having a syncopal event after getting the COVID-19 vaccine.  She states that she was otherwise feeling well today, exercise on her Peloton bike today with no problems, received her COVID vaccine and shortly after her vaccine started to feel dizzy and light headed. She tells me she was reading an article on her phone about cats when she suddenly started to feel dizzy, lightheaded, felt like she could not see, and she could not feel her hands and legs.  The next thing she remembers is receiving a shot of epinephrine.  She denies any lip swelling, tongue swelling, rashes on her body, or extremity itchiness.  Currently states that she feels like the back of her throat he has a little bit itchy.  Denies any abdominal pain, headache, neck pain, or numbness or weakness at this time.   She was given 0.3mg SQ epi x 2 in the pharmacy. When medics arrived on scene, she was awake, moving all extremities, lungs were clear bilaterally.  Blood pressure was 130/90, heart rate was 100 (NSR).    She tells me her two biggest complaints at this time is that she feels like her heart is racing after the epinephrine shot and she has some mild itchiness in the back of her throat.   Reports she has a history of allergy to multiple medications and an allergy to the chickenpox vaccine.
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood glucose, Blood magnesium, Culture urine, Dizziness, Electrocardiogram
Clinical narrative: History of Present Illness     This is a healthy 33-year-old female presenting to the emergency depart with medics after having a syncopal event after getting the COVID-19 vaccine.  She states that she was otherwise feeling well today, exercise on her Peloton bike today with no problems, received her COVID vaccine and shortly after her vaccine started to feel dizzy and light headed. She tells me she was reading an article on her phone about cats when she suddenly started to feel dizzy, lightheaded, felt like she could not see, and she could not feel her hands and legs.  The next thing she remembers is receiving a shot of epinephrine.  She denies any lip swelling, tongue swelling, rashes on her body, or extremity itchiness.  Currently states that she feels like the back of her throat he has a little bit itchy.  Denies any abdominal pain, headache, neck pain, or numbness or weakness at this time.   She was given 0.3mg SQ epi x 2 in the pharmacy. When medics arrived on scene, she was awake, moving all extremities, lungs were clear bilaterally.  Blood pressure was 130/90, heart rate was 100 (NSR).    She tells me her two biggest complaints at this time is that she feels like her heart is racing after the epinephrine shot and she has some mild itchiness in the back of her throat.   Reports she has a history of allergy to multiple medications and an allergy to the chickenpox vaccine.
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Full blood count, Hypoaesthesia, Hypokalaemia, Metabolic function test, Pregnancy test
Clinical narrative: History of Present Illness     This is a healthy 33-year-old female presenting to the emergency depart with medics after having a syncopal event after getting the COVID-19 vaccine.  She states that she was otherwise feeling well today, exercise on her Peloton bike today with no problems, received her COVID vaccine and shortly after her vaccine started to feel dizzy and light headed. She tells me she was reading an article on her phone about cats when she suddenly started to feel dizzy, lightheaded, felt like she could not see, and she could not feel her hands and legs.  The next thing she remembers is receiving a shot of epinephrine.  She denies any lip swelling, tongue swelling, rashes on her body, or extremity itchiness.  Currently states that she feels like the back of her throat he has a little bit itchy.  Denies any abdominal pain, headache, neck pain, or numbness or weakness at this time.   She was given 0.3mg SQ epi x 2 in the pharmacy. When medics arrived on scene, she was awake, moving all extremities, lungs were clear bilaterally.  Blood pressure was 130/90, heart rate was 100 (NSR).    She tells me her two biggest complaints at this time is that she feels like her heart is racing after the epinephrine shot and she has some mild itchiness in the back of her throat.   Reports she has a history of allergy to multiple medications and an allergy to the chickenpox vaccine.
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Presyncope, Syncope, Throat irritation, Visual impairment
Clinical narrative: History of Present Illness     This is a healthy 33-year-old female presenting to the emergency depart with medics after having a syncopal event after getting the COVID-19 vaccine.  She states that she was otherwise feeling well today, exercise on her Peloton bike today with no problems, received her COVID vaccine and shortly after her vaccine started to feel dizzy and light headed. She tells me she was reading an article on her phone about cats when she suddenly started to feel dizzy, lightheaded, felt like she could not see, and she could not feel her hands and legs.  The next thing she remembers is receiving a shot of epinephrine.  She denies any lip swelling, tongue swelling, rashes on her body, or extremity itchiness.  Currently states that she feels like the back of her throat he has a little bit itchy.  Denies any abdominal pain, headache, neck pain, or numbness or weakness at this time.   She was given 0.3mg SQ epi x 2 in the pharmacy. When medics arrived on scene, she was awake, moving all extremities, lungs were clear bilaterally.  Blood pressure was 130/90, heart rate was 100 (NSR).    She tells me her two biggest complaints at this time is that she feels like her heart is racing after the epinephrine shot and she has some mild itchiness in the back of her throat.   Reports she has a history of allergy to multiple medications and an allergy to the chickenpox vaccine.
Age: 27.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Anaphylactic reaction, Endotracheal intubation, Intensive care, Mouth swelling, Pharyngeal swelling
Clinical narrative: Patient had swelling of lips and tongue within 15 minutes of vaccination.  Given Benedryl and epi and transported to ER by EMS.   Report from ER:  She had anaphylaxis with progressive tongue swelling despite multiple doses of IM epi and an epi drip.  She was ultimately intubated to secure her airway in the face of potential airway compromise.
Age: 27.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Acidosis, Anaphylactic reaction, Dyspnoea, Endotracheal intubation, Hypoperfusion
Clinical narrative: Patient had swelling of lips and tongue within 15 minutes of vaccination.  Given Benedryl and epi and transported to ER by EMS.   Report from ER:  She had anaphylaxis with progressive tongue swelling despite multiple doses of IM epi and an epi drip.  She was ultimately intubated to secure her airway in the face of potential airway compromise.
Age: 27.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Hypotension, Intensive care, Swollen tongue
Clinical narrative: Patient had swelling of lips and tongue within 15 minutes of vaccination.  Given Benedryl and epi and transported to ER by EMS.   Report from ER:  She had anaphylaxis with progressive tongue swelling despite multiple doses of IM epi and an epi drip.  She was ultimately intubated to secure her airway in the face of potential airway compromise.
Age: 27.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Anaphylactic reaction, Endotracheal intubation, Lip swelling, Swollen tongue
Clinical narrative: Patient had swelling of lips and tongue within 15 minutes of vaccination.  Given Benedryl and epi and transported to ER by EMS.   Report from ER:  She had anaphylaxis with progressive tongue swelling despite multiple doses of IM epi and an epi drip.  She was ultimately intubated to secure her airway in the face of potential airway compromise.
Age: 43.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Rash
Clinical narrative: Patient recieved vaccine on Monday 3/29/21 around 9:30am, he started to feel itchy same day around belly button but as the week went by the rash increased (looks like bumps and no puss), looks like a hives rash some places looks worse than others and looks patchy. He also c/o bilateral swelling in hands/fingers. No c/o fever, bodyaches, chills, headache, sob. As of 4/7/21 @3:45pm swelling has subsided but the itchyness and rash is not getting better. Patient took Benadryl, and applied Triamcinolone cream, and also took Xyzal.  Advised patient to continue with the Benadryl/Xyzal to help with the allergic reaction. He may also apply benadryl cream and hydrocortisone cream to help. Informed patients wife that if he experiences any fever/body aches/chills to take Tylenol or Ibuprofen but if he experiences any SOB or chest pain then proceed to the Urgent Care or ER.  The brother in law is a Dermatologist which he prescribed him the Triamcinolone cream.  4/9-Follow up: Patients wife called back and stated that patient is still itchy (almost 2 weeks) but it's drying up now. She stated he is still taking benadryl and applying the triamincinolone cream. Advised to continue with the Benadryl/Xyal and benadryl cream. Will follow back up on 4/12/21.
Age: 43.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Peripheral swelling, Pruritus, Rash, Urticaria
Clinical narrative: Patient recieved vaccine on Monday 3/29/21 around 9:30am, he started to feel itchy same day around belly button but as the week went by the rash increased (looks like bumps and no puss), looks like a hives rash some places looks worse than others and looks patchy. He also c/o bilateral swelling in hands/fingers. No c/o fever, bodyaches, chills, headache, sob. As of 4/7/21 @3:45pm swelling has subsided but the itchyness and rash is not getting better. Patient took Benadryl, and applied Triamcinolone cream, and also took Xyzal.  Advised patient to continue with the Benadryl/Xyzal to help with the allergic reaction. He may also apply benadryl cream and hydrocortisone cream to help. Informed patients wife that if he experiences any fever/body aches/chills to take Tylenol or Ibuprofen but if he experiences any SOB or chest pain then proceed to the Urgent Care or ER.  The brother in law is a Dermatologist which he prescribed him the Triamcinolone cream.  4/9-Follow up: Patients wife called back and stated that patient is still itchy (almost 2 weeks) but it's drying up now. She stated he is still taking benadryl and applying the triamincinolone cream. Advised to continue with the Benadryl/Xyal and benadryl cream. Will follow back up on 4/12/21.
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Interchange of vaccine products
Clinical narrative: I received my first Covid short (Pfizer) on  March 15th. Upon arrival for my scheduled second covid (pfizer) shot, they administered the Moderna shot due to a "communication error" amongst the staff.
Age: 33.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Abdominal distension, Benign lymph node neoplasm, Chest pain, Lymph node pain, Lymphadenopathy
Clinical narrative: Severe swelling; tenderness and soreness under the left armpit; Severe soreness at injection site (outer left arm); Severe soreness; fatigue; This is a spontaneous report from a contactable consumer (patient). A 33-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection), dose 2 via an unspecified route of administration, administered in Arm Left on 18Feb2021 1:15 pm (Batch/Lot Number: EL0982) as SINGLE DOSE for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications included Nature's Way Alive Max3 Daily multivitamin. The patient had previously received first dose of bnt162b2 (BNT162B2) on 29-JAN-2021 at 1:15 pm (Lot number: EL3246) for covid-19 immunisation. On 19Feb2021 at 12:00 pm the patient experienced severe swelling, tenderness and soreness under the left armpit, severe soreness  and fatigue .The treatment for events was unknown. The action taken in response to the event(s) for bnt162b2 was not applicable. Outcome of events was unknown.
Age: 33.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Ultrasound scan
Clinical narrative: Severe swelling; tenderness and soreness under the left armpit; Severe soreness at injection site (outer left arm); Severe soreness; fatigue; This is a spontaneous report from a contactable consumer (patient). A 33-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection), dose 2 via an unspecified route of administration, administered in Arm Left on 18Feb2021 1:15 pm (Batch/Lot Number: EL0982) as SINGLE DOSE for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications included Nature's Way Alive Max3 Daily multivitamin. The patient had previously received first dose of bnt162b2 (BNT162B2) on 29-JAN-2021 at 1:15 pm (Lot number: EL3246) for covid-19 immunisation. On 19Feb2021 at 12:00 pm the patient experienced severe swelling, tenderness and soreness under the left armpit, severe soreness  and fatigue .The treatment for events was unknown. The action taken in response to the event(s) for bnt162b2 was not applicable. Outcome of events was unknown.
Age: 33.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Fatigue, Swelling, Tenderness, Vaccination site pain
Clinical narrative: Severe swelling; tenderness and soreness under the left armpit; Severe soreness at injection site (outer left arm); Severe soreness; fatigue; This is a spontaneous report from a contactable consumer (patient). A 33-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection), dose 2 via an unspecified route of administration, administered in Arm Left on 18Feb2021 1:15 pm (Batch/Lot Number: EL0982) as SINGLE DOSE for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications included Nature's Way Alive Max3 Daily multivitamin. The patient had previously received first dose of bnt162b2 (BNT162B2) on 29-JAN-2021 at 1:15 pm (Lot number: EL3246) for covid-19 immunisation. On 19Feb2021 at 12:00 pm the patient experienced severe swelling, tenderness and soreness under the left armpit, severe soreness  and fatigue .The treatment for events was unknown. The action taken in response to the event(s) for bnt162b2 was not applicable. Outcome of events was unknown.
Age: 30.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Seizure
Clinical narrative: Immediately after the shot, started to feel a little faint. After a few minutes started to feel nauseated, and lightheaded. Fainted and fell out of the chair. Came to and was a little disoriented at first. Taken to the hospital, and they determined that the cause of fainting was vasovagal syncope.
Age: 30.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Disorientation, Dizziness, Electrocardiogram, Fall, Full blood count
Clinical narrative: Immediately after the shot, started to feel a little faint. After a few minutes started to feel nauseated, and lightheaded. Fainted and fell out of the chair. Came to and was a little disoriented at first. Taken to the hospital, and they determined that the cause of fainting was vasovagal syncope.
Age: 30.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Metabolic function test, Nausea, Syncope
Clinical narrative: Immediately after the shot, started to feel a little faint. After a few minutes started to feel nauseated, and lightheaded. Fainted and fell out of the chair. Came to and was a little disoriented at first. Taken to the hospital, and they determined that the cause of fainting was vasovagal syncope.
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Face injury, Fatigue, Loss of consciousness, Nasal injury
Clinical narrative: 03/25 - day after shot, developed calf tightness, weakness, chills, shortness of breath, and headache.  discomfort continued for several days. 04/05 - SOB continues to increase, patient experienced lightheadedness and passed out without losing consciousness. 04/06 - continues to have increasing SOB, fainted and lost consciousness. 04/08 - ultrasound done to leg, found DVT, sent to ER
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain in extremity, Tachycardia
Clinical narrative: 03/25 - day after shot, developed calf tightness, weakness, chills, shortness of breath, and headache.  discomfort continued for several days. 04/05 - SOB continues to increase, patient experienced lightheadedness and passed out without losing consciousness. 04/06 - continues to have increasing SOB, fainted and lost consciousness. 04/08 - ultrasound done to leg, found DVT, sent to ER
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Angiogram pulmonary abnormal, Asthenia, Chills, Computerised tomogram thorax, Deep vein thrombosis
Clinical narrative: 03/25 - day after shot, developed calf tightness, weakness, chills, shortness of breath, and headache.  discomfort continued for several days. 04/05 - SOB continues to increase, patient experienced lightheadedness and passed out without losing consciousness. 04/06 - continues to have increasing SOB, fainted and lost consciousness. 04/08 - ultrasound done to leg, found DVT, sent to ER
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Discomfort, Dizziness, Dyspnoea, Headache, Loss of consciousness
Clinical narrative: 03/25 - day after shot, developed calf tightness, weakness, chills, shortness of breath, and headache.  discomfort continued for several days. 04/05 - SOB continues to increase, patient experienced lightheadedness and passed out without losing consciousness. 04/06 - continues to have increasing SOB, fainted and lost consciousness. 04/08 - ultrasound done to leg, found DVT, sent to ER
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Muscle tightness, Pulmonary embolism, Scan with contrast, Syncope, Ultrasound Doppler abnormal
Clinical narrative: 03/25 - day after shot, developed calf tightness, weakness, chills, shortness of breath, and headache.  discomfort continued for several days. 04/05 - SOB continues to increase, patient experienced lightheadedness and passed out without losing consciousness. 04/06 - continues to have increasing SOB, fainted and lost consciousness. 04/08 - ultrasound done to leg, found DVT, sent to ER
Age: 76.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Aphasia, Confusional state, Gait inability, Loss of consciousness, Oxygen saturation decreased
Clinical narrative: Pt recieved  2nd  Moderna Covid Shot,  April  5.    thirty min later, pt  lowed to the ground with generalized Seizure lasting about one min.  followed by post ictal confsuion.   Pt remained confused, so brought to the emergency room on the 6th where I saw him.  He was awake, but confused, knew his name, but that is about it.   He was released from the hospital today.   I speak with his daughter, he  has been in a stupor, but today his mental status is improving..
Age: 76.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pyrexia, Tremor
Clinical narrative: Pt recieved  2nd  Moderna Covid Shot,  April  5.    thirty min later, pt  lowed to the ground with generalized Seizure lasting about one min.  followed by post ictal confsuion.   Pt remained confused, so brought to the emergency room on the 6th where I saw him.  He was awake, but confused, knew his name, but that is about it.   He was released from the hospital today.   I speak with his daughter, he  has been in a stupor, but today his mental status is improving..
Age: 76.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Magnetic resonance imaging head normal, Postictal state, Seizure, Stupor
Clinical narrative: Pt recieved  2nd  Moderna Covid Shot,  April  5.    thirty min later, pt  lowed to the ground with generalized Seizure lasting about one min.  followed by post ictal confsuion.   Pt remained confused, so brought to the emergency room on the 6th where I saw him.  He was awake, but confused, knew his name, but that is about it.   He was released from the hospital today.   I speak with his daughter, he  has been in a stupor, but today his mental status is improving..
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pruritus, Respiratory tract congestion, Throat tightness
Clinical narrative: Patient received 1st dose Moderna vaccine. After vaccination found to have white nodules on posterior tongue/mouth. Patient described increased difficulty breathing and chest pressure. Patient stated has history of asthma. Physical exam and vital signs completed by RN and NP. Pt. A&O X 3, GCS 15, RR 18, BP 107/58 HR 60, no other findings on exam. Patient received benadryl 25mg PO. EMS called at this time. Upon arrival of EMS transfer of care without incident.
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest discomfort, Dyspnoea, Hypotension, Oral mucosal eruption, Physical examination
Clinical narrative: Patient received 1st dose Moderna vaccine. After vaccination found to have white nodules on posterior tongue/mouth. Patient described increased difficulty breathing and chest pressure. Patient stated has history of asthma. Physical exam and vital signs completed by RN and NP. Pt. A&O X 3, GCS 15, RR 18, BP 107/58 HR 60, no other findings on exam. Patient received benadryl 25mg PO. EMS called at this time. Upon arrival of EMS transfer of care without incident.
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Respiratory rate increased, Tongue eruption, Vital signs measurement
Clinical narrative: Patient received 1st dose Moderna vaccine. After vaccination found to have white nodules on posterior tongue/mouth. Patient described increased difficulty breathing and chest pressure. Patient stated has history of asthma. Physical exam and vital signs completed by RN and NP. Pt. A&O X 3, GCS 15, RR 18, BP 107/58 HR 60, no other findings on exam. Patient received benadryl 25mg PO. EMS called at this time. Upon arrival of EMS transfer of care without incident.
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Heart rate decreased, Hyperhidrosis, Hypotension, Lethargy, Loss of consciousness
Clinical narrative: Immediate feeling of "oddness" then loss of consciousness.  Awoke to consciousness of being surrounded by EMT personnel, oxygen mask in place, IV line in right arm, heart monitoring electrodes on chest. Hearing someone asking questions from a great distance but being unable to answer. Hearing snatches of conversation from EMTs. "Was unresponsive," "heartrate is 30," "BP is extremely low," "Heartrate begins to come up then falls back to 30." Finally was able to speak at first in a faint mumble, then more normally. Heart rate is still in 30s. Was taken by ambulance to hospital.
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pallor
Clinical narrative: Immediate feeling of "oddness" then loss of consciousness.  Awoke to consciousness of being surrounded by EMT personnel, oxygen mask in place, IV line in right arm, heart monitoring electrodes on chest. Hearing someone asking questions from a great distance but being unable to answer. Hearing snatches of conversation from EMTs. "Was unresponsive," "heartrate is 30," "BP is extremely low," "Heartrate begins to come up then falls back to 30." Finally was able to speak at first in a faint mumble, then more normally. Heart rate is still in 30s. Was taken by ambulance to hospital.
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Echocardiogram normal, Feeling abnormal, Full blood count normal, Influenza A virus test negative, Influenza B virus test
Clinical narrative: Immediate feeling of "oddness" then loss of consciousness.  Awoke to consciousness of being surrounded by EMT personnel, oxygen mask in place, IV line in right arm, heart monitoring electrodes on chest. Hearing someone asking questions from a great distance but being unable to answer. Hearing snatches of conversation from EMTs. "Was unresponsive," "heartrate is 30," "BP is extremely low," "Heartrate begins to come up then falls back to 30." Finally was able to speak at first in a faint mumble, then more normally. Heart rate is still in 30s. Was taken by ambulance to hospital.
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Influenza virus test negative, Loss of consciousness, SARS-CoV-2 test negative, Troponin normal
Clinical narrative: Immediate feeling of "oddness" then loss of consciousness.  Awoke to consciousness of being surrounded by EMT personnel, oxygen mask in place, IV line in right arm, heart monitoring electrodes on chest. Hearing someone asking questions from a great distance but being unable to answer. Hearing snatches of conversation from EMTs. "Was unresponsive," "heartrate is 30," "BP is extremely low," "Heartrate begins to come up then falls back to 30." Finally was able to speak at first in a faint mumble, then more normally. Heart rate is still in 30s. Was taken by ambulance to hospital.